DJIA 17,071.03 20.28 0.12%
NASDAQ 4,825.59 14.81 0.31%
S&P 500 2,014.80 1.37 0.07%
market minute promo

Gilead Sciences (NASDAQ: GILD)

100.38 -0.43 (-0.43%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $100.33 -0.48%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.27
Previous Close $100.81
Daily Range $99.90 - $101.80
52-Week Range $85.95 - $123.37
Market Cap $147.3B
P/E Ratio 10.60
Dividend (Yield) $1.72 (1.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,644,066
Average Daily Volume 12,618,144
Current FY EPS $11.99




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

2 Reasons Gilead Sciences Suffered Through a Rough September

Gilead Sciences lost $10 billion in market value last month. Find out why this biotech blue-chip stock dropped, and whether you should bet on a rebound.

4 Biotech Stocks Now at Bargain Prices

UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings

'Fast Money' Recap: Avoid Alcoa on Its Disappointing Earnings

Gilead Is About to Disappoint Investors -- but for All the Right Reasons

Wall Street is hoping Gilead is gearing up for a major buyout soon. One Motley Fool thinks this scenario is both unlikely and unnecessary. Here's why.

Why We Should Take This Biotech Selloff Seriously

3 Pharma Stocks With Big Margins of Safety

Looking to add a few stocks to your portfolio that offer a healthy margin of safety? Here are a few names to consider.

Biotech: Secular Change Or Just Temporary Sentiment Shift?

Stocks Rally as March Rate Hike Most Likely

Stock Market News for October 08, 2015

See More GILD News...

GILD's Top Competitors

GILD $100.38 (-0.43%)
Current stock: GILD
AMGN $149.85 (-0.03%)
Current stock: AMGN
CELG $117.12 (-0.72%)
Current stock: CELG
$0.00 (0.00%)
Current stock: